BioAnalytical Method Development

Resources

BioAnalytical Method Development: LinkedIn

BioAnalytical Method Development: labroots

BioAnalytical Method Development: ResearchGATE

Future of BioPharma Blog

Who can you meet at Cell Based Assays & Bioanalytical Method Development 2010?
Over the past 5 years, the Cell Based Assays and Bioanalytical Method Development Conference has been the only place to learn from the scientists at the forefront of new approaches and solutions to the assay development obstacles you face everyday. ...
Novartis breaks through on meningitis vaccine
Novartis UK has made a breakthrough that could result in a vaccination for Meningitis B according to the UK Gazette. The recent clinical trial proved to be successful. Meningitis B is the most common form of the disease, and 6%, approximately 1,200...
Biosimialrs market expcted to expand with health care reform
According to Pharma Live, by 2017, the biosimilars sector will reach $10 billion dollars. While healthcare reform is expected to hit the biotech sector in one way, the reform will allow them access to more patients in the United States, as well as r...
As personalized treatment grows, patient access to biorepositories is shaky
The Richmond Times-Dispatch recently wrote an article looking at the growing importance of biostorage in the fight for personalized cancer treatment. As cancer moves away from the all-in-one chemotherapy treatments, it's moving towards using tissue ...
Who can you meet next week at Business of Biosimilars?
The Business of Biosimilars event is taking place next week! It's not too late to register and join these industry leaders: AARP * Abbott Laboratories * Alston & Bird * American Enterprise Institute * Amgen Inc * BD Medical Pharmaceutical Systems * ...
Infectious diseases focus of research for vaccines
Infectious diseases are still a large cause of death around the world even though scientists have made major advancements in treating these diseases since the 1920s. Fierce Biotech states that there are currently 395 currently in the late stage of d...
Call for global approach to developing biosimilars
The European Generics Industry is calling for a world wide standard to develop biosimilars. Leaders believe standards need to be set for the industry world wide in order to create a consistent, scientific global approach in order to fully reach the ...
Who Will You Meet at BIOREPOSITORIES 2010?
The nation's leading biobanking experts gather annually at The Biorepositories Event to cultivate a strategic perspective for sample management and exchange biorepository best practices throughout the sample lifecycle. Bring your business cards and ...
The Changing Landscape of Biosimilars
The most recent issue of Pharmaceutical Technology Europe, they profile the landscape of biosimilars. In this issue they cover The Biosimilars Market of Today and Tomorrow, A SWOT analysis of the biosimilars market, Latest EU Guidelines, Launching a...
Cell Based Assays: An Interveiw with Xu-Rong Jiang, MedImmune
Speaker and Cell Based Assays Track Chair Xu-Rong Jiang, PhD, MD, Associate Director, Analytical Biochemistry, MedImmune, recently commented on the case study he'll be presenting at this year's conference taking place October 4-6, 2010, in San Franci...

Download 2008 Presentations

	PK Assay Strategies for Biotherapeutics Alyssa Morimoto, PhD, Scientist, BioAnalytical Research and Development Genentech
	Quantitative Evaluation of Effects of FucoseDepletion on FcγRIIIA Binding and ADCC Activities of A Humanized IgG1 Antibody Shan Chung, Ph.D. Genentech, Inc.

In The News

Event Information

Registration

Conference Brochure

Member Log In

Send To A Friend

Related Events

Find another IIR Event

Customer Service

Add Event To Calendar

Resources

Resources